Why Should You Attend:

Having inherited a handful of drug cost-cutting final rules proposed by the Trump White House, the Biden Administration has put forward a series of its own drug pricing initiatives even as Congress is poised to act on legislation containing key drug cost- cutting policies relating to Medicare & drug prices more generally.

Title Index:

– Background on prescription drug pricing issue
– Biden Administration reaction to Trump era drug pricing rules
– Impact of Biden White House executive order for reducing prescription drug prices
– Analysis of Biden call for Congress to cut drug costs including having Medicare negotiate drug prices
– Overview of HHS Drug Pricing Plan
– Review of key state actions impacting drug prices
– Senate finance committee principles for lowering drug prices & pending drug pricing bills in Congress
– Legislative status of infrastructure and budget reconciliation bills having drug pricing provisions.
– Pharma reacts to federal initiatives on drug pricing.
– Analysis of dynamics shaping federal actions on drug pricing in 2021 plus outlook for year ahead

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.